Abstract
IMMUNOLOGICAL cardiac injury can be produced in experimental animals by the administration of: (a) homologous or heterologous heart extract with Freund's adjuvant; (b) passive transfer of humoral anticardiac antibodies; or (c) after passive transfer of cellular antibodies either through intravenous injections of immune cell suspension or by transplantation of immune spleens1.
Similar content being viewed by others
References
Chaturvedi, U. C., and Mehrotra, R. M. L., Ind. J. Med. Res., 55, 21 (1967).
Miller, J. F. A. P., Ann. NY Acad. Sci., 99, 340 (1962).
Martinez, C., Kersey, J., Papermaster, B. W., and Good, R. A., Proc. Soc. Exp. Biol. and Med., 109, 193 (1962).
Archer, O., Pierce, J. C., Papermaster, B. W., and Good, R. A., Nature, 195, 191 (1962).
Jankovic, B. D., Waksman, B. H., and Arnason, B. G., J. Exp. Med. 116, 159 (1962).
Arnason, B. G., Jankovic, B. D., Waksman, B. H., and Wennersten, C., J. Exp. Med., 116, 177 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CHATURVEDI, U., MEHROTRA, R. Effect of Neonatal Thymectomy on Experimentally Produced Immunological Cardiac Lesions. Nature 216, 267–268 (1967). https://doi.org/10.1038/216267a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/216267a0
- Springer Nature Limited
This article is cited by
-
Cardiomyopathy and myocarditis — A review of new aspects in research in West Germany
Heart and Vessels (1985)